Ardelyx reported $-0.07 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
0.04 Nov/03
-0.07 -0.03 -0.08 Aug/06
FY2025Q1 Mar/2026 -0.15 -0.12 -0.17 Apr/30




Eps Change Date
Abbott USD 0.53 0.78 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
Ardelyx USD -0.07 0.08 Jun/2026
aTyr Pharma USD -0.05 0.01 Jun/2026
Corcept Therapeutics USD 1.01 0.65 Sep/2026
Curis USD -11.82 13.04 Mar/2026
Sanofi EUR 0.14 2.02 Jun/2026
TG Therapeutics USD 0.35 0.3 Sep/2026
United Therapeutics USD 5.71 1.56 Sep/2026